U.S. federal trademark · Serial No. 79322364 · Reg. No. 6976289
Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.